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1. Introduction 
Recent studies in this laboratory have demonstrated 
that a new trialkyltin analogue, dibutylchloromethyltin 
chloride (DBCT), inhibits oxidative phosphorylation 
in yeast mitochondria by reacting covalently with a 
non-protein lipid cofactor associated with the mito- 
chondrial inner membrane and the ATP synthase 
(oligomycin-sensitive ATPase) complex and which 
has been provisionally identified by thin-layer 
chromatography (t.1.c.) and bioassay as lipoic acid 
[l] . In addition dihydrolipoate will specifically reverse 
the inhibitory effects of DBCT [l] . Other dithiols 
including dihydrolipoamide are ineffective, indicating 
that reversal of inhibition is due to replacement of 
the DBCT-titrated cofactor by dihydrolipoate with 
consequent restoration of ATP synthesis and ATP- 
driven energy-linked reactions. 
During the course of these studies it was observed 
that dibutyltin dichloride (DBT), the precursor used 
for DBCT synthesis, was also a potent inhibitor of 
the yeast oligomycin-sensitive ATPase [l] . Previous 
studies of Aldridge and Cremer [2] had indicated that 
the inhibition of oxidative phosphorylation by 
dialkyltin compounds was due to the inhibitor react- 
ing with the dihydrolipoate cofactor in the pyruvate 
and a-ketoglutarate dehydrogenase complexes. This 
paper describes studies which demonstrate that DBT 
not only titrates the dihydrolipoate found in the pyru- 
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vate dehydrogenase and cu-ketoglutarate dehydrogenase 
complexes involved in substrate level phospborylation, 
but also the dihydrolipoate cofactor pool found in 
the membrane-bound oligomycin-sensitive ATPase 
complex with a consequent inhibition of oxidative 
phosphorylation and ATP-driven energy-linked reac- 
tions. These findings also demonstrate that dialkyltin 
compounds are very useful dithiol reagents which 
function at low concentrations and do not suffer from 
the permeability problems associated with arsenite, 
the classical dithiol reagent. 
2. Materials and methods 
The sources of all the chemicals used in this study 
have been described previously [ 1,3] . Dibutyltin 
dichloride was further purified by fractional distillation 
as described previously [l] . 
Ox heart mitochondria (BHM) and submitochon- 
drial particles (BHSMP) were prepared as described by 
Griffiths et al. [3] . Mitochondrial respiration, ATP- 
driven transhydrogenase, ATP-driven reduction of 
NAD’ by succinate, oxidative phosphorylation and 
ATPase activity were measured as described previously 
[3] . Protein and Pi determination were as described 
by Griffiths et al. [3]. 
The reaction of DBT with SH compounds was 
studied essentially as described by Aldridge and 
Cremer [2] using the dye 2,6-dichlorophenolindo- 
phenol (DCPIP) which is decolorised by thiols. The 
various thiol compounds were incubated in 2 ml 
20 mM Tris/HCl, pH 7.5, buffer with and without the 
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inhibitor for 5 min at 1%20°C before adding 0.5 ml 
buffer containing 40 ,ug DCPIP. The rate of decolorisa- 
tion of the dye was followed at 620 nm in a Unicam 
SP 1800 spectrophotometer. R is the ratio of inhibitor 
to -SH compound and T,, the time in seconds for 
50% decolorisation of the dye. 
3. Results 
Figure la shows that DBT inhibits ADP stimulated 
respiration of mitochondria utilizing pyruvate + malate 
as substrates (1se value approx. 3 nmol/mg protein), 
but unlike DBCT and other trialkyltin compounds, 
uncoupler stimulated respiration is also inhibited. A 
similar result was obtained using cY-ketoglutarate as a 
substrate. However, using succinate as a substrate 
(fig.lb), a different result is obtained in that even 
when using an excess of DBT (3 1 nmol/mg protein) 
only the ADP-stimulated respiration is inhibited and 
no effect is seen on the uncoupler-stimulated respira- 
tion. This finding indicates that DBT has a mode of 
action similar to the classical inhibitors of oxidative 
phosphorylation, oligomycin and the trialkyltin com- 
pounds. Therefore DBT has two inhibitory sites of 
action on mitochondrial respiration: 
6) 
(ii > 
As demonstrated previously [2] , an effect on the 
cw-ketoglutarate and pyruvate dehydrogenase 
complexes leading to the inhibition of pyruvate 
and cY-ketoglutarate oxidation. 
An inhibition of the ADP-stimulated respiration 
which does not involve a direct action on the 
respiratory chain and is analogous to the energy- 
transfer inhibitors, oligomycin and the trialkyltin 
compounds. 
These findings suggest hat DBT may have a direct 
effect on the ATP synthase complex. This conclusion 
was examined by studying ATP synthesis in submito- 
chondrial particles. ATP synthesis using NADH, succi- 
nate and ascorbate + Nail-tetra-methyl-~-phenyl- 
enediamine as substrate is inhibited by DBT (Is,, 
value approx. 6 nmol/mg protein) demonstrating that 
ATP synthesis utilising all three segments of the 
respiratory chain is inhibited and indicating that there 
is a common site of action, i.e., the energy-transfer 
reaction in the ATP synthase complex. 
This conclusion is supported by the experiments 
shown in fig.2. which show that DBT is also a potent 
inhibitor of the ATP-driven reduction of NAD’ by 
succinate (Zse value 2.3 nmol/mg protein). The inhib- 
itory effects are unusual in that a ‘lag phase’ is 
produced which is proportional to the amount of inhib. 
itor added. These findings are similar to those found 
for DBCT [4]. Figure 2 also shows that the ATP- 
driven transhydrogenase reaction is also inhibited by 
DBCT (I,, value 6.3 nmol/mg protein). In contrast 
L 
Fig.1. Inhibition of mitochondrial respiration by DBT. Mito- 
chondrial respiration was recorded as described by Griffiths 
et al. [3]. Inhibitors were added as indicated in maximum 
vol. 5 r.11 ethanol. (a) The reaction medium contained 2.25 mg 
BHM to which the following additions were made: PM, 
10 wmol pyruvate + 1 Fmol malate; ADP, 900 nmol; FCCP, 
10 nmol. In addition, 5 r.11 ethanol was added at (I), control; 
6.3 nmol of DBCT at (2); 3.3,6.6 and 13.2 nmol DBT added 
at (3), (4), (5). (b) The following additions were made to the 
reaction medium which contained 1.6 mg BHM; Succ, 
10 pmol succinate; PM, 10 pmol pyruvate + 1 nmol malate; 
ADP, 600 nmol; FCCP, 10 nmol. In addition 5 ~1 ethanol was 
added at (1); 70 nmol DBT at (2), (3). 
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Fig.2. Inhibition by DBT of the ATPdriven reduction of 
NAD+ by succinate. (a) The ATPdriven reduction of NAD+ 
by succinate was assayed as described by Griffiths et al. 
[3] with 1 mg BHSMP. The following additions were made: 
(1) no addition; (2) 0.52 nmol DBT; (3) 1.24 nmol DBT; 
(4) 1.8 nmol DBT; (5) 3.1 nmol DBT; (6) 12.5 nmol DBT. 
(b) ATPdriven and succinate (Succ.)driven transhydrogenase 
were assayed as previously described [3] with 1 mg BHSMP. 
The following additions were carried out: (1) no additions; 
(2) 8.3 nmol DBT; (3) 16.4 nmol DBT; (4) no additions; 
(5) 18.5 nmol DBT. 
the succinate-driven (i.e., respiratory chain-driven) 
transhydrogenase reaction is unaffected by DBT even 
at a concentration of 13.5 nmol/mg protein. 
These results clearly show that DBT is acting on 
the ATP synthase (oligomycin-sensitive ATPase) 
complex and a direct assay of ATPase activity in 
BHSMP revealed that DBT was a potent inhibitor (Iso 
value 2.8 nmol/mg protein). However, DBT had no 
effect on the purified heart Fr -ATPase [7] even at a 
concentration of 82 nmol/mg protein, demonstrating 
that the effect of DBT is on the membrane compo- 
nents of the oligomycin-sensitive ATPase complex. 
This result is supported by the finding that the puri- 
fied oligomycin-sensitive ATPase preparation from 
yeast mitochondria is also sensitive to DBT (Cain, K. 
and Griffiths, D. E., unpublished results). 
These studies clearly show that DBT has a mode of 
action which is similar to DBCT and is a direct inhibi- 
tory effect on the ATPsynthase (oligomycin-sensitive 
ATPase) complex resulting in the inhibition of ADP- 
stimulated respiration, oxidative phosphorylation, 
ATP-driven energy-linked reactions and ATPase 
activity. In the case of DBCT, the inhibitory actions 
are specifically reversible by dihydrolipoate due to the 
dithiol compound apparently replacing a cofactor 
which has been titrated by the DBCT. The identity of 
the cofactor has been provisionally characterised as 
lipoic acid. 
Consequently, we have investigated the effects of 
dithiol compounds on the inhibitory actions of DBT 
on ATP synthesis and ATPase activity (tables 1 and 2). 
The inhibitory effects can be reversed by a variety of 
dithiol compounds including dihydrolipoate, and even 
the monothiol glutathione. In addition lipoate or lipo- 
amide, under appropriate preincubation conditions, 
will also produce some reversal of the inhibitory 
effects. presumably due to the oxidised compound 
being slowly reduced by the respiratory chain. Table 3 
shows that DBT rapidly reacts with dithiols but not 
with monothiols such as glutathione. The reversal of 
the inhibitory actions of DBT by a variety of dithiol 
compounds is probably a ‘scavenging’ effect resulting 
from a displacement of the cofactor from the DBT- 
cofactor complex. by dithiol interchange reactions 
analogous to those involved in reversal of arsenite 
inhibition of dithiols [8] . 
4. Discussion 
The original work by Aldridge and Cremer [2] 
demonstrated that dialkyltin compounds inhibit the 
cu-ketoglutarate and pyruvate dehydrogenase com- 
plexes by reacting with the protein-bound dihydro- 
lipoate cofactor; the inhibitory effects of the dialkyl- 
tins could be reversed by the addition of dithiols. The 
results presented here for DBT confirm these con- 
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Table 1 
Reversal of DBT-inhibited oxidative phosphorylation by various thiol compounds 
Additions ATP synthesised 
(nmol/20 min) 
Activity 
(% control) 
No DBT (control) 2.83 100 
DBT 1.1 39 
DBT + reduced glutathione (20) 2.7 95 
DBT + dihydrolipoate (20) 2.65 94 
DBT + dithiothreitol(20) 2.8 99 
DBT + 2,3dimercaptopropanol (20) 2.83 100 
DBT + dihydrolipoamide (20) 2.60 92 
DBT + lipoate (20) 1.1 41 
DBT + lipoamide (20) 1.1 39 
BHSMP were preincubated in 0.25 M sucrose, 20 mM Tris-HCl, pH 7.5, 1 mM 
EDTA buffer at 10 mg/ml with DBT (6 nmol/mg protein). 100 ~1 (1 mg) was 
removed and added to 1 ml phosphorylation buffer and then shaken for 5 mm 
with the indicated additions at 30°C. The phosphorylation assay was then started 
by the addition of 10 rmol succinate and then carried out as described by Griffiths 
et al. 131. The figures in brackets refer to nmol indicated compound/mg protein 
Table 2 
Reversal of DBT-inhibited ATPase activity by various thiol compounds 
Additions nnol Pi/min/mg Activity 
(% Control) 
No DBT (control) 2.5 100 
DBT 0.75 30 
DBT dihydrolipoate (10) 2.35 94.4 
DBT + reduced glutathione (10) 2.16 86.7 
DBT + dithiothreitol (20) 2.39 95.9 
DBT + 2,3-dimercaptopropanol (20) 2.41 99 
DBT + lipoate (20) 0.75 30 
DBT + dihydrolipoamide (20) 2.41 91 
ATPase was assayed at 30°C by release of Pi [ 31. BHSMP were preincubated with 
DBT (4.9 nmol/mg protein) at 10 mg/ml for 30 min at 4°C. A 10 ~1 aliquot was 
then removed to the ATPase assay and the indicated thiol compound added, 
followed immediately by ATP. Figures in brackets refer to the final concentration 
(nmol) in 1 ml ATPase buffer 
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Table 3 
Reaction of DBT with various thiol compounds 
_ 
SH compound SH compound (PM) DBT (/.rM) R T,, 6) 
- DBT + DBT 
Dihydrolipoate 250 58 0.23 15 60 
250 81 0.34 15 410 
250 145 0.6 15 not reached after 600 
Dithiothreitol 81 109 1.34 24 84 
81 182 2.24 24 120 
Glutathione 163 364 2.23 120 100 
Dihydrolipoamide 71 58 0.75 42 1% in 360 
2,3-Dimercaptopropanol 119 36.5 0.3 12 24 
119 72.7 0.61 12 60 
119 218 1.83 12 3% in 360 
The reaction of the inhibitor with SH groups was determined by the method of Aldridge and Cremer (1955), using the dye 
2,6-dichlorophenolindophenol which is decolourised by SH groups. The indicated compounds were incubated in 2 ml 20 mM 
Tris-HCl, pH 7.5, buffer with and without the inhibitor for 15 min at 18-20°C before adding 0.5 ml buffer containing 40 pg 
2,6-dichlorophenolindophenol. The rate of decolourisation of the dye was followed at 620 nm in a Unicam SP 1800 spectro- 
photometer 
elusions; thus uncoupler-stimulated respiration in 
BHM is inhibited when pyruvate + malate and cy-keto- 
glutarate are used as substrates. However, the results 
with mitochondrial respiration utilising succinate 
clearly show that there is another site of action 
involving energy-transfer eactions in the ATP syn- 
thase complex. This is confirmed by the inhibition 
of ATP-driven energy-linked reactions and mito- 
chondrial ATPase activity which show that the ATP 
synthase complex is inhibited by DBT. The reversal 
of the inhibitory effects of DBT on the ATP synthase 
complex by dithiol compounds demonstrates that 
DBT inhibition of ATP-dependent reactions also 
involves a dithiol residue, presumably the lipoate 
cofactor pool present in the inner mitochondrial 
membrane and the ATP synthase complex. 
therefore the inhibitory effects of DBT which occur at 
Ise values around 3-6 nmol/mg protein and maximal 
inhibition approx. IO-15 nmol/mg protein are pro- 
duced by concentrations of the inhibitor which would 
be expected to titrate the lipoic acid cofactor ‘pool’. 
Titration of this ‘pool’ with DBCT results in inhibition 
which can only be reversed by the replacement of the 
titrated cofactor with dihydrolipoate. In the case of 
DBT a variety of dithiols are effective and the mecha- 
nism of reversal is probably a ‘scavenging’ action due 
to a displacement of the cofactor from the DBT- 
cofactor complex by the dithiol reagent. 
The inhibitory effects of DBT on the ATP synthase 
complex are similar to those described for DBCT 
[ 1,4-61 which has been shown to inhibit ADP- 
stimulated respiration, ATP synthesis, ATPdriven 
energy-linked reactions and ATPase activity by titrat- 
ing a lipoic acid cofactor in the inner mitochondrial 
membrane and ATP synthase complex. The concentra- 
tion of this cofactor is around 6-9 nmol/mg protein, 
These experiments further reinforce the previous 
conclusions [l] that DBCT is a unique inhibitor for 
titrating the lipoic acid cofactor present in the mito- 
chondrial inner membrane and that DBT is also an 
extremely useful dithiol reagent with a similar mode 
of action but lacks the specificity exhibited by DBCT. 
As DBT is a lipophilic inhibitor and freely permeable 
to membranes, it is a useful dithiol reagent for investi- 
gating membrane-bound enzymes and offers experi- 
mental advantages over arsenite and the arsenical-type 
dithiol reagents. 
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